Does stress hyperglycemia worsen cardiac outcomes through increased inflammatory immune processes in MI patients?
Stress hyperglycemia during acute MI may lead to poor cardiac outcomes by driving an increased inflammatory immune response.
During MI, hyperglycemia is associated with increased levels of inflammatory markers, enhanced expression of cytotoxic T-cells, and reduced expression of T-cells, which are implicated in limiting the immune process. An increased inflammatory immune process seems a likely mechanism linking acute hyperglycemia to poor cardiac outcome in MI patients.
Marfella et al. (Sat,) studied this question.